26-A-8401-ACC SACUBITRIL-VALSARTAN REDUCES H-FABP, HS-CTNT, HS-CRP AND MONOCYTE-TO-LYMPHOCYTE RATIO IN ANTHRACYCLINE-TREATED PRECLINICAL MODELS THROUGH INHIBITION OF NLRP3/IL1β SIGNALING
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Cardiac Fibrosis and Remodeling
Inflammasome and immune disorders
Chemotherapy-induced cardiotoxicity and mitigation
Publication details
- Journal / source
- Journal of the American College of Cardiology
- Volume
- 87
- Issue
- 13
- Pages
- A1084–A1084
- Publication date
- 27 March 2026
- Language
- EN